Recent Analyst Forecasts and Stock Ratings
Neurocrine Biosciences, Inc. FAQ's
Neurocrine Biosciences, Inc. has been rated by research analysts at RBC Capital, Truist Financial, UBS, Mizuho Securities, Stifel Nicolaus, BMO Capital in the past 90 days.